Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Sonnet BioTherapeutics Holdings
AddedFeb 20, 2024
UpdatedJun 18, 2026
Sonnet BioTherapeutics Holdings

Sonnet BioTherapeutics Holdings

Public

NJ-based Sonnet BioTherapeutics develops innovative, targeted biologic drugs using human albumin binding technology.

Founded
1999
Overview
Compare
Employees
Website

Founded in Princeton, New Jersey, Sonnet BioTherapeutics Holdings is a clinical-stage biotechnology company with a core mission to revolutionize cancer treatment. The company leverages its proprietary FHAB™ (Fully Human Albumin Binding) technology to develop innovative, targeted biologic drugs that feature enhanced single- or bi-specific mechanisms. Sonnet BioTherapeutics focuses on creating immune therapeutics that directly combat cancer, aiming to improve patient outcomes through advanced biologic solutions.

Notable figures affiliated with Sonnet BioTherapeutics include key scientists and industry experts who contribute to the company's groundbreaking research and development efforts. The company has attracted significant investment from venture capital firms and strategic partners, underscoring confidence in its technology and vision. Among its key achievements, Sonnet has successfully advanced several drug candidates into clinical trials, demonstrating the potential of its FHAB platform. Overall, Sonnet BioTherapeutics is making a substantial impact in the field of oncology by pioneering next-generation immune therapeutics.

Sonnet BioTherapeutics Holdings - Quick Facts

When was Sonnet BioTherapeutics Holdings founded?

Sonnet BioTherapeutics Holdings was founded in 1999.

How many employees does Sonnet BioTherapeutics Holdings have?

Sonnet BioTherapeutics Holdings has 12 employees as of Feb 6, 2024.

Sonnet BioTherapeutics Holdings - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biologic Drugs
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 54 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541611Administrative Management and General Management Consulting Services
  • 541612Human Resources Consulting Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 561300Employment Services
  • 561310Employment Placement Agencies and Executive Search Services
  • 561312Executive Search Services
  • 711100Performing Arts Companies
  • 711110Theater Companies and Dinner Theaters
  • 720000Accommodation and Food Services
  • 722000Food Services and Drinking Places
  • 722300Special Food Services
  • 722310Food Service Contractors
  • 722320Caterers
  • 722500Restaurants and Other Eating Places
  • 722510Restaurants and Other Eating Places
  • 722511Full-Service Restaurants
  • 722513Limited-Service Restaurants
  • 722514Cafeterias, Grill Buffets, and Buffets
  • 722515Snack and Nonalcoholic Beverage Bars
  • 560000Administrative and Support and Waste Management and Remediation Services
  • 620000Health Care and Social Assistance
  • 710000Arts, Entertainment, and Recreation
  • 541000Professional, Scientific, and Technical Services
  • 561000Administrative and Support Services
  • 711000Performing Arts, Spectator Sports, and Related Industries
  • 541600Management, Scientific, and Technical Consulting Services
  • 541700Scientific Research and Development Services
  • 541610Management Consulting Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 541613Marketing Consulting Services
  • 541614Process, Physical Distribution, and Logistics Consulting Services
SIC
  • 5800Eating and drinking places
  • 5810Eating And Drinking Places
  • 5812Eating Places
  • 9900Nonclassifiable Establishments
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 6000Depository Institutions
  • 6700Holding And Other Investment Offices
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8740Management And Public Relations Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
  • 8742Management Consulting Services
ISIC
  • 5610Restaurants and mobile food service activities
  • 5621Event catering
  • 5629Other food service activities
  • 7020Management consultancy activities
  • 7810Activities of employment placement agencies
  • 9000Creative, arts and entertainment activities